CapsoVision (NASDAQ:CV) Major Shareholder Eliyahou Et Al Harari Acquires 81,300 Shares

CapsoVision, Inc. (NASDAQ:CV) major shareholder Eliyahou Et Al Harari bought 81,300 shares of the firm’s stock in a transaction on Wednesday, July 8th. The stock was bought at an average cost of $6.09 per share, for a total transaction of $495,117.00. Following the transaction, the insider directly owned 3,282,051 shares of the company’s stock, valued at $19,987,690.59. The trade was a 2.54% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Eliyahou Et Al Harari also recently made the following trade(s):

• On Friday, June 26th, Eliyahou Et Al Harari purchased 13,850 shares of CapsoVision stock. The shares were bought at an average price of $7.35 per share, with a total value of $101,797.50.

CapsoVision Stock Up 3.8%

Shares of CV traded up $0.22 during trading on Friday, reaching $5.99. 87,049 shares of the company traded hands, compared to its average volume of 234,181. The stock has a 50-day simple moving average of $6.87 and a 200-day simple moving average of $6.71. The stock has a market cap of $299.26 million and a PE ratio of -2.56. CapsoVision, Inc. has a twelve month low of $3.43 and a twelve month high of $15.37.

CapsoVision (NASDAQ:CV) last issued its quarterly earnings data on Thursday, May 14th. The company reported ($0.15) earnings per share for the quarter. The company had revenue of $2.79 million for the quarter.

Institutional Trading of CapsoVision

A number of hedge funds and other institutional investors have recently modified their holdings of the company. State Street Corp lifted its holdings in shares of CapsoVision by 340.7% in the fourth quarter. State Street Corp now owns 85,929 shares of the company’s stock valued at $919,000 after buying an additional 66,429 shares during the period. Bank of New York Mellon Corp bought a new stake in CapsoVision in the first quarter worth about $359,000. Geode Capital Management LLC raised its position in CapsoVision by 34.1% in the fourth quarter. Geode Capital Management LLC now owns 154,264 shares of the company’s stock worth $1,649,000 after acquiring an additional 39,231 shares in the last quarter. Citadel Advisors LLC acquired a new stake in CapsoVision in the 3rd quarter valued at about $115,000. Finally, Bank of America Corp DE lifted its holdings in CapsoVision by 528.9% in the 1st quarter. Bank of America Corp DE now owns 22,238 shares of the company’s stock valued at $162,000 after acquiring an additional 18,702 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on CV shares. Benchmark decreased their price objective on CapsoVision from $14.00 to $10.00 and set a “speculative buy” rating for the company in a report on Friday, March 27th. Weiss Ratings reissued a “sell (d-)” rating on shares of CapsoVision in a research note on Monday, June 29th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, CapsoVision has an average rating of “Moderate Buy” and a consensus price target of $8.50.

About CapsoVision

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.